GB8824592D0 - Purification process - Google Patents

Purification process

Info

Publication number
GB8824592D0
GB8824592D0 GB888824592A GB8824592A GB8824592D0 GB 8824592 D0 GB8824592 D0 GB 8824592D0 GB 888824592 A GB888824592 A GB 888824592A GB 8824592 A GB8824592 A GB 8824592A GB 8824592 D0 GB8824592 D0 GB 8824592D0
Authority
GB
United Kingdom
Prior art keywords
purification process
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888824592A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Free Hospital School of Medicine
Original Assignee
Royal Free Hospital School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Free Hospital School of Medicine filed Critical Royal Free Hospital School of Medicine
Priority to GB888824592A priority Critical patent/GB8824592D0/en
Publication of GB8824592D0 publication Critical patent/GB8824592D0/en
Priority to JP1511014A priority patent/JPH04501356A/ja
Priority to EP89911826A priority patent/EP0439502A1/en
Priority to PCT/GB1989/001263 priority patent/WO1990004650A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
GB888824592A 1988-10-20 1988-10-20 Purification process Pending GB8824592D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB888824592A GB8824592D0 (en) 1988-10-20 1988-10-20 Purification process
JP1511014A JPH04501356A (ja) 1988-10-20 1989-10-20 精製方法
EP89911826A EP0439502A1 (en) 1988-10-20 1989-10-20 A purification process for covalently bound dna/protein complexes
PCT/GB1989/001263 WO1990004650A1 (en) 1988-10-20 1989-10-20 A purification process for covalently bound dna/protein complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888824592A GB8824592D0 (en) 1988-10-20 1988-10-20 Purification process

Publications (1)

Publication Number Publication Date
GB8824592D0 true GB8824592D0 (en) 1988-11-23

Family

ID=10645512

Family Applications (1)

Application Number Title Priority Date Filing Date
GB888824592A Pending GB8824592D0 (en) 1988-10-20 1988-10-20 Purification process

Country Status (4)

Country Link
EP (1) EP0439502A1 (ja)
JP (1) JPH04501356A (ja)
GB (1) GB8824592D0 (ja)
WO (1) WO1990004650A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5545529A (en) * 1993-01-27 1996-08-13 New York University Assay for detecting covalent DNA-protein complexes
GB9317618D0 (en) * 1993-08-24 1993-10-06 Royal Free Hosp School Med Polymer modifications
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US5629384A (en) * 1994-05-17 1997-05-13 Consiglio Nazionale Delle Ricerche Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
JP2001508783A (ja) * 1997-01-29 2001-07-03 ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー Peg化法
GB2338237B (en) * 1997-02-18 2001-02-28 Actinova Ltd In vitro peptide or protein expression library
GB9703369D0 (en) * 1997-02-18 1997-04-09 Lindqvist Bjorn H Process

Also Published As

Publication number Publication date
EP0439502A1 (en) 1991-08-07
WO1990004650A1 (en) 1990-05-03
JPH04501356A (ja) 1992-03-12

Similar Documents

Publication Publication Date Title
GB9120902D0 (en) Purification process
ZA883887B (en) Chromatographic purification process
ZA871634B (en) Alpha-1-antiprotease purification
HU905046D0 (en) Process for purifying n-phosphono-methyl-glycine
GB8822875D0 (en) Purification process
GB8824592D0 (en) Purification process
GB8817270D0 (en) Novel process
IL86601A0 (en) Chromatographic purification process
GB9107344D0 (en) Purification process
GB8807288D0 (en) Novel process
GB9107087D0 (en) Purification process
GB8814340D0 (en) Process
GB9102750D0 (en) Purification process
GB8916925D0 (en) Water purification process
GB8824068D0 (en) Santising process
GB8802484D0 (en) Process
GB8824672D0 (en) Process
GB8800487D0 (en) Purification process
GB8800312D0 (en) Process
GB9011661D0 (en) Purification process
GB8908461D0 (en) Purification process
GB8717479D0 (en) Purification process
GB8709288D0 (en) Purification process
ZA869332B (en) Purification process
GB8630770D0 (en) Purification process